Patients should stop the medication and contact their healthcare provider immediately if they experience: Severe or persistent abdominal pain (especially if radiating to the back), which could indicate pancreatitis Persistent vomiting preventing adequate fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Yellowing of skin or eyes (jaundice) or pale stools Unexplained fever Severe diarrhoea lasting more than 48 hours Treatment continuation is reviewed regularly, with decisions based on efficacy, tolerability, and ongoing clinical need
Scientific studies have highlighted semaglutides efficacy in facilitating significant weight loss, including reductions in visceral fat
Talk to your doctor or pharmacist before starting or adjusting any semaglutide regimen, and verify current FDA importation guidelines before placing a cross-border order.
doi: 10.3389/fendo.2023.1170881 [DOI] [PMC free article] [PubMed] [Google Scholar] 29.Schou M, Petrie MC, Borlaug BA, et al
According to the Wegovy SmPC, patients with a history of pancreatitis should use Wegovy with caution